Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 70 citing articles:

American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus
George Grunberger, Jennifer L. Sherr, Myriam Bermudez Allende, et al.
Endocrine Practice (2021) Vol. 27, Iss. 6, pp. 505-537
Closed Access | Times Cited: 201
Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study
Jingyi Lu, Chunfang Wang, Yun Shen, et al.
Diabetes Care (2020) Vol. 44, Iss. 2, pp. 549-555
Open Access | Times Cited: 183
Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring
Michael Yapanis, Steven James, Maria E. Craig, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 6, pp. e2221-e2236
Open Access | Times Cited: 159
Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes
Timothy C. Dunn, Ramzi Ajjan, Richard M. Bergenstal, et al.
Diabetes Technology & Therapeutics (2024) Vol. 26, Iss. 3, pp. 203-210
Open Access | Times Cited: 21
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
Ramzi Ajjan, Tadej Battelino, Xavier Cos, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 7, pp. 426-440
Closed Access | Times Cited: 18
A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100
Ildiko Lingvay, John B. Buse, Edward Franek, et al.
Diabetes Care (2021) Vol. 44, Iss. 7, pp. 1595-1603
Open Access | Times Cited: 71
Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review
Rishi Raj, Rahul Mishra, Nivedita Jha, et al.
BMJ Open Diabetes Research & Care (2022) Vol. 10, Iss. 1, pp. e002573-e002573
Open Access | Times Cited: 49
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
Grazia Aleppo, Roy W. Beck, Ryan Bailey, et al.
Diabetes Care (2021) Vol. 44, Iss. 12, pp. 2729-2737
Open Access | Times Cited: 51
Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy
Junpeng Yang, Xueli Yang, Dongni Zhao, et al.
Journal of Diabetes Investigation (2020) Vol. 12, Iss. 5, pp. 828-836
Open Access | Times Cited: 50
The Association of Time in Range and Diabetic Complications: The Evidence Is Strong
Roy W. Beck
Diabetes Technology & Therapeutics (2023) Vol. 25, Iss. 6, pp. 375-377
Closed Access | Times Cited: 16
Association between glycaemia risk index (GRI) and diabetic retinopathy in type 2 diabetes: A cohort study
Yaxin Wang, Jingyi Lu, Jiaying Ni, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 9, pp. 2457-2463
Open Access | Times Cited: 16
Intra‐pancreatic fat is associated with continuous glucose monitoring metrics
Yutong Liu, Wandia Kimita, Xiatiguli Shamaitijiang, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 6, pp. 2359-2367
Open Access | Times Cited: 6
Correlation Between Glycemic Variability and Diabetic Complications: A Narrative Review
Lining Huang, Ying Pan, Kaixin Zhou, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 3083-3094
Open Access | Times Cited: 13
Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study
Ramzi Ajjan, Tadej Battelino, Jochen Seufert, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e085961-e085961
Open Access
Correlation between key indicators of continuous glucose monitoring and the risk of diabetic foot
Xinqian Geng, Shun-Fang Chen, Fei-Ying Wang, et al.
World Journal of Diabetes (2025) Vol. 16, Iss. 3
Closed Access
The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetes
Tadej Battelino, Nebojša Lalić, Sufyan Hussain, et al.
Diabetes Research and Clinical Practice (2025), pp. 112111-112111
Open Access
Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study
Norihiro Kuroda, Yoshiki Kusunoki, Keiko Osugi, et al.
Journal of Diabetes Investigation (2020) Vol. 12, Iss. 2, pp. 244-253
Open Access | Times Cited: 34
Time-in-range as a target in type 2 diabetes: An urgent need
Banshi Saboo, Jothydev Kesavadev, Arun Shankar, et al.
Heliyon (2021) Vol. 7, Iss. 1, pp. e05967-e05967
Open Access | Times Cited: 30
Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study
Thomas Danne, Matthias Axel Schweitzer, Winfried Keuthage, et al.
Diabetes Technology & Therapeutics (2020) Vol. 23, Iss. 3, pp. 203-212
Open Access | Times Cited: 29
The Association Between Continuous Glucose Monitoring-Derived Metrics and Cardiovascular Autonomic Neuropathy in Outpatients with Type 2 Diabetes
Min Young Kim, Gyuri Kim, Ji Yun Park, et al.
Diabetes Technology & Therapeutics (2021) Vol. 23, Iss. 6, pp. 434-442
Closed Access | Times Cited: 26
Continuous Glucose Monitoring Impact and Implications of Real-World Evidence: Past, Present, and Future
James R. Gavin, Clifford J. Bailey
Diabetes Technology & Therapeutics (2023) Vol. 25, Iss. S3, pp. S-13
Open Access | Times Cited: 9
Research progress on the association between glycemic variability index derived from CGM and cardiovascular disease complications
Lei Zhang, Xiaoxuan Sun, Qingshan Tian
Acta Diabetologica (2024) Vol. 61, Iss. 6, pp. 679-692
Closed Access | Times Cited: 3
Correlation Between Blood Urea Nitrogen and Short- and Long-Term Glycemic Variability in Elderly Patients with Type 2 Diabetes Mellitus Who Were hospitalized:A Retrospective Study
Lining Huang, Zhaoxiang Wang, Ying Pan, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 1973-1986
Open Access | Times Cited: 3
Time in Range: How to Measure It, How to Report It, and Its Practical Application in Clinical Decision-Making
Eugene E. Wright, Kayla Morgan, Danny K. Fu, et al.
Clinical Diabetes (2020) Vol. 38, Iss. 5, pp. 439-448
Open Access | Times Cited: 25
When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD
Alba Rojano‐Toimil, Jesús Rivera‐Esteban, Ramiro Manzano-Núñez, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3286-3286
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top